Pediatrix Medical Group, Inc. (MD)
(Delayed Data from NYSE)
$7.68 USD
0.00 (0.00%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $7.68 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth D Momentum D VGM
Brokerage Reports
0 items in cart
Pediatrix Medical Group, Inc. [MD]
Reports for Purchase
Showing records 241 - 260 ( 343 total )
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Raising estimates for anesthesia acquisition and Medicaid parity ruling
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
3Q Beats By $0.05. 4Q Guidance Well Above Consensus. Reimbursement Parity Will Help In 2013, 2014. Anesthesia Acceleration Just Beginning. Expect Breakout Year In 2013. Affirm Buy Rating And $95 PT.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Better than expected results; CMS finalizes Medicaid parity, estimates to increase
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Preliminary low weight birth data reflects solid 3Q12 trends
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Investor Meeting Highlights Anesthesia Opportunity. Acceleration Just Beginning. Expect Breakout .
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Analyst Day sets the stage for national anesthesia presence
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
MD Q2/12 Surprise on upside, Acquisition activity picks up Maintain Buy and $80.00 price target
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
MD Better than expected results inline with our propriety research; raising estimates
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
MD: Solid 2Q. Anesthesia To Accelerate. Reimbursement To Increase. Affirm Buy And Raise PT To $95.
Provider: COLLIERS SECURITIES
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Preliminary birth weight data suggests improving Pediatrix trends
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
ACA Should Result In Favorable Reimbursement. Also Expect Anesthesia Acceleration To Contribute To Faster Growth. Affirm Buy Rating And $80 PT.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
MD: Q1/2012 results in line; Maintain Buy
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
MD: 2Q To Be Soft. Expect Anesthesia Acceleration To Drive Growth.Affirm Buy Rating. Reducing PT From $100 To $80.
Provider: COLLIERS SECURITIES
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
MD: 4Q In Line. Anesthesia Acceleration Will Drive Growth. Affirm Buy Rating And Raise PT From $90 To $100.
Provider: COLLIERS SECURITIES
Analyst: CHAULAGAI D
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Mixed quarterly results; accelerating M&A pace to provide earnings upside?
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
4Q11 Preview: Cautious on quarterly volumes; remain focused on stabilizing trends
Provider: FELTL & COMPANY
Analyst: WEIGHT M